Your session is about to expire
← Back to Search
Study Summary
This trial is to test the safety and effectiveness of the H3 TAR Prosthesis.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- The skin and tissue around my surgery area are in poor condition.My legs have poor blood flow as shown by a Doppler test.My bones are too weak to support a medical device due to severe osteoporosis or similar conditions.You participate in high-intensity sports that involve physical contact or jumping.I have had surgery on my ankle before, either a fusion or a replacement.My foot cannot lay flat due to its shape or alignment.I am currently on immunosuppressive therapy.I have a condition that affects my ankle muscle function.You have a known allergy or intolerance to metal.My knee joint is significantly misaligned.My ankle ligament support is too weak and cannot be fixed with surgery.My bones are still growing.I have nerve damage in my foot that could lead to joint problems.I have had a serious infection in my ankle or nearby bones.I have bone death in my ankle due to lack of blood supply.I have arthritis suitable for total ankle replacement as decided by my doctor.
- Group 1: Treatment Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there opportunities for enrollment in this medical trial?
"Affirmative. According to clinicaltrials.gov, the recruitment process for this medical study has been ongoing since February 1st 2022 and was most recently updated on June 10th 2022. A total of 232 patients are needed from 4 different trial sites."
How many individuals is the research team recruiting for this investigation?
"DT MedTech, LLC will be overseeing the trial from two locations: Duke Orhtopaedics Arringdon in Morrisville, North carolina and Los Angeles Institute of Foot and Ankle Surgery in Mission Hills, California. The study necessitates 232 patients that meet all inclusion criteria to commence operations."
How many healthcare facilities are currently conducting this research project?
"This study is accessible through four medical sites, such as Duke Orhtopaedics Arringdon in Morrisville, Los Angeles Institute of Foot and Ankle Surgery in Mission Hills, Dept. of Orthopedic Surgery and Rehabilitation from the University of Oklahoma at Oklahoma City, with other locations also available."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger